Cell & Gene Meeting on the Med 2024, an ARM Conference

Meet Veristat in Rome at the Meeting on the Med Conference 2024, 9-11 April 2024 

With nearly 30 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program. 

If you are transitioning your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help. 

The Science-First CRO.™

The scientific full service CRO and consultancy integrating strategic planning, regulatory strategy, and clinical trial execution to rapidly advance your complex or novel therapies. In the past five years, our team members have supported more than 350 clinical trials and consulting projects for rare diseases and have worked on more than 40+ US and European regulatory marketing applications – 30 of which have been approved so far.

Don't miss this opportunity to connect with us.

Schedule A Meeting

Veristat team members will be at the venue, ready to listen to your needs and share more about Veristat’s expertise: 

John Balser, PhD, Founder, President & Chief Statistical Officer 
Barbara Balser, VMD, Founder, Executive Vice President & Chief Scientific Officer
Rachel Page,  Chief Commercial Officer
Patrick Flanagan, Chief Executive Officer

You can arrange a meeting by completing the form on the right side of this page. Discover how we can assist you in progressing in your upcoming project

Conference Details

Website: MEETING ON THE MED